Stryker Corp. (NYSE:SYK) named a new international group president to take over as Andrew Fox-Smith resigned from the position to pursue other career opportunities.
Ramesh Subrahmanian takes the role, effective September 1, after having most recently served as senior VP and president, Asia Pacific, for Merck & Co. (NYSE:MRK).
"Ramesh brings a strong global perspective to Stryker through his successful leadership roles in the U.S., Germany, India and Asia Pacific," Stryker president & CEO Stephen MacMillan said in prepared remarks. "He is a proven healthcare leader who has demonstrated the ability to drive profitable growth and innovation, and we look forward to taking advantage of his varied experiences as we continue to grow our international businesses."
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Wright Medical executive exodus continues
Wright Medical Group Inc. (NSDQ:WMGI) VP and chief compliance officer Lisa Michels stepped down, effective immediately, adding to the pattern of executives disappearing from the Arlington, Tenn.-based maker of orthopedic devices maker.
Wright fired its chief technology officer on the same day it accepted the resignation of its CEO Gary Henly in April, and three more senior executives resigned "without good reason" in May as the company continued to deal with the fallout from an alleged kickbacks scheme.
- Neoprobe elects Gordon Troup board chairman
Neoprobe Corp. (NYSE Amex:NEOP), which recently announced that it had sold its name along with its radiation detection arm to Devicor Medical Products Inc., named Gordon Troup chairman of the board, succeeding Carl Aschinger, who held the position since July 2007.
- TearScience poaches Allergan leader
Morrisville, N.C.-based TearScience Inc. named former Allergan Inc. (NYSE:AGN) global division head and corporate VP to senior VP for the privately held medical device company.
- Tangent Medical announces CEO and board chairman
Ann Arbor, Mich.-based development stage device company Tangent Medical Technologies Inc. named Jeff Williams board chairman and CEO. Williams was most recently president & CEO of Accuri Cytometers, which sold for $205 million in March 2011.
- Electromed CFO steps down
New Prague, Minn.-based airway clearance device maker Electromed Inc.’s (NSDQ:ELMD) CFO retired, effective on either October 31 or when a replacement is found.
- Encision announces new president & CEO
Boulder, Colo.-based surgical technology company Encision Inc. (PINK:ECIA) named Fred Perner president & CEO, succeeding Jack Serino who stepped down to pursue other interests.
- Osprey names new clinical and regulatory VP
Minneapolis, Minn.-based contrast induced nephropathy company Osprey Medical named Dan Mans VP of clinical and regulatory affairs. Mans comes with more than 20 years of med-tech experience, including stints at Voyageur Medical, American Medical Systems Holdings Inc. (NSDQ:AMMD) and Medtronic Inc. (NYSE:MDT).